Sanofi opens $925-million flu vaccine facility in Toronto

Sanofi inaugurates Toronto facility that will produce seasonal flu vaccines for Canadians

French pharmaceutical maker’s site is also designed to provide new capacity for vaccine production in event of another pandemic

Sanofi opens $925-million flu vaccine facility in Toronto

Sanofi has officially opened a massive new flu‑vaccine manufacturing facility in Toronto — a $925‑million project billed as the largest single bio-manufacturing investment in Canadian history. The Charles Best Building, located on Sanofi’s 52‑acre Toronto campus, will produce Fluzone High‑Dose, a high‑potency influenza vaccine designed for adults 65 and older, who account for the majority […]

Ontario - Ontario Celebrates Grand Opening of Sanofi's Newest Biomanufacturing Facility

On September 16, the Ontario government joined Sanofi, a global biopharmaceutical company, to celebrate the official inauguration of their new $925 million vaccine manufacturing facility at the hist. . .